Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05616104
Other study ID # VMG-2022-001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 29, 2022
Est. completion date February 2024

Study information

Verified date April 2023
Source VentureMed Group Inc.
Contact Jill Schweiger
Phone 763-296-2021
Email jschweiger@venturemedgroup.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities following 12 months post treatment.


Description:

Prospective, observational study evaluating the clinical use and outcomes of the FLEX Vessel Prep (VP) system in arteriovenous fistulae or grafts presenting with clinical or hemodynamic abnormalities in real-world subjects per the Institution's standard practice and at 1-, 6-, and 12-months following treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date February 2024
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Subject is =18 years of age. 2. Subject is currently scheduled to undergo an endovascular intervention of arteriovenous fistula or graft due to clinical and hemodynamic abnormalities meeting the KDOQI Guidelines for AV access dysfunction: - Elevated venous pressure during hemodialysis, - Abnormal physical findings, and - Unexplained decrease in delivered dialysis dose. 3. Subject has a reasonable expectation of remaining on hemodialysis for =12 months. 4. Subject is legally competent, informed of the study, voluntarily agrees to participate, and signs the informed consent form. 5. Subject understands the study and is willing and able to comply with the follow-up requirements. Exclusion Criteria: 1. Subject has a known or suspected systemic infection. 2. Subject has a known or suspected infection of the hemodialysis graft. 3. Subject has an untreatable allergy to radiographic contrast material. 4. In the opinion of the operating physician, the subject's hemodialysis access is unsuitable for endovascular treatment.

Study Design


Intervention

Device:
FLEX Vessel Prep System
The FLEX Vessel Prep System to create circumferential, continuous micro-incisions along the length of the stenosis by performing a retrograde pullback through the lesion. Following FLEX, standard balloon angioplasty is performed with an uncoated PTA balloon sized to meet the reference vessel diameter, according to its corresponding Instructions for Use. Once advanced into the lesion, the balloon should be inflated according to the site's standard of care.

Locations

Country Name City State
United States Open Access Vascular Access Miami Florida
United States Minneapolis Vascular Surgery Center New Brighton Minnesota
United States Dialysis Access Institute Orangeburg South Carolina
United States Spartanburg Regional Health Spartanburg South Carolina

Sponsors (1)

Lead Sponsor Collaborator
VentureMed Group Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Target Lesion Primary Patency Rate Defined as freedom from clinically driven target lesion re-intervention (CD-TLR) or access circuit thrombosis measured through 6-months post- procedure. 6 months post procedure
Primary Serious Adverse Event Rate Defined as the Serious Adverse Event (SAE) rate involving the AV access circuit through 1-month post-procedure. 1 month
See also
  Status Clinical Trial Phase
Completed NCT03724279 - Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Not yet recruiting NCT02841488 - Ischemic Pain Control With Analgesic Methods Clinical Trial Phase 3
Completed NCT00371371 - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) Phase 1/Phase 2
Completed NCT00174759 - CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease Phase 3
Completed NCT00209443 - A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide Phase 3
Completed NCT00000539 - Arterial Disease Multifactorial Intervention Trial (ADMIT) Phase 3
Recruiting NCT04089943 - The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD N/A
Recruiting NCT04343209 - Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
Not yet recruiting NCT05930145 - Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke N/A
Recruiting NCT04142021 - Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
Completed NCT03253692 - Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Active, not recruiting NCT04624854 - Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) Phase 4
Active, not recruiting NCT02921230 - Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery N/A
Recruiting NCT02593994 - IRIS-Onyx Cohort in the IRIS-DES Registry
Completed NCT02008097 - Clinical Benefits of B-Flow Ultrasound N/A
Terminated NCT01462721 - The eSVS® Mesh Randomized Post-Market Study N/A
Completed NCT00282646 - Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD) Phase 2
Not yet recruiting NCT04956523 - Preliminary Tissue Monitoring During Endovascular Intervention Study
Not yet recruiting NCT04175197 - LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries